Fetal antipsychotic exposure in a changing landscape: seeing the future
- 1 May 2013
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 202 (5) , 321-323
Abstract
Summary Pregnant women and their fetuses are increasingly likely to be exposed to antipsychotics. However, safety data remain limited. This editorial suggests that, in future, well-designed observational pharmaco-epidemiology is our best chance of illuminating risk for exposed populations and of informing decision-making for women and clinicians.Keywords
This publication has 11 references indexed in Scilit:
- Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort studyBMJ, 2012
- Antipsychotics During PregnancyArchives of General Psychiatry, 2012
- Mental Illness, Women, Mothers and their Children2011
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology, 2011
- Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference?Schizophrenia Research, 2010
- Maternal Use of Antipsychotics in Early Pregnancy and Delivery OutcomeJournal of Clinical Psychopharmacology, 2008
- Parental mental illness and fatal birth defects in a national birth cohortPsychological Medicine, 2007
- Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical OutcomesAmerican Journal of Psychiatry, 2007
- Pregnancy Outcome of Women Using Atypical Antipsychotic DrugsThe Journal of Clinical Psychiatry, 2005
- Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelinesAmerican Journal of Psychiatry, 1996